eXoZymes Inc. (EXOZ)
Nasdaq: EXOZ · Biological Products, (No Diagnostic Substances) · Monrovia, CA · filing with the SEC since 2024
Who runs eXoZymes Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Heltzen Michael
Chief Executive Officer. First filing Nov 2024, latest Sep 2, 2026, 4 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
12 people on the record since 2024
Officerssales are open-market, Oct 26, 2025 to Oct 26, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Perriman Damien Alan | Chief Commercial Officer | Apr 2026 | Oct 26, 2026 | 1 · $0.00 |
| Korman Tyler Paz | Chief Scientific Officer | Nov 2024 | Oct 21, 2026 | 2 · $0.00 |
| Nawaz Fouad | Vice President- Finance | Nov 2024 | Sep 17, 2026 | none |
| Heltzen Michael | Chief Executive Officer | Nov 2024 | Sep 2, 2026 | none |
| Opgenorth Paul Hideo | Vice President, Development | Nov 2024 | Apr 8, 2026 | none |
Directorssales are open-market, Oct 26, 2025 to Oct 26, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bell Lon E | director | Nov 2024 | Oct 19, 2026 | none |
| Bowie James Ulrich | director | Nov 2024 | Oct 19, 2026 | none |
| Digiandomenico Anthony | director | Nov 2024 | Oct 19, 2026 | none |
| Lalonde James Joseph | director | Nov 2024 | Oct 19, 2026 | none |
| Marlett Christopher A | director | Nov 2024 | Oct 19, 2026 | none |
| Rayo Edgardo Javier | director | Mar 2025 | Oct 19, 2026 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.